We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Achilles Heel in Dengue Virus Discovered

By LabMedica International staff writers
Posted on 26 Apr 2015
Print article
Image: Illustration of the 3D structure of antibody complexes for all four serotypes bound to the Dengue virus envelope protein (Image courtesy of Institut Pasteur).
Image: Illustration of the 3D structure of antibody complexes for all four serotypes bound to the Dengue virus envelope protein (Image courtesy of Institut Pasteur).
Image: Illustration of human patient antibodies binding to a Dengue virus particle (Image courtesy of Imperial College London).
Image: Illustration of human patient antibodies binding to a Dengue virus particle (Image courtesy of Imperial College London).
Researchers have found new hope for a vaccine against dengue fever after discovering a vulnerable site on the surface of the Dengue virus that is targeted by the only broadly neutralizing human antibodies identified to date.

The discovery, from research led by scientists at Imperial College London (London, UK) and Institut Pasteur (Paris, France), offers a new target for development of a vaccine to combat all 4 types (serotypes DEN-1, DEN-2, DEN-3, DEN-4) of Dengue virus currently in circulation. Though a patient produces antibodies specific to one serotype during an initial infection, these do not confer effective protection against subsequent infection by the other serotypes. These antibodies may even constitute a risk factor for developing a severe, often fatal form of dengue – dengue hemorrhagic fever. Any future vaccine against dengue must therefore provide effective, simultaneous protection against all four.

“Current vaccine trials have shown some promise but do not fully protect from infection. The finding of this new class of antibodies points the way for a new approach,” said Prof. Gavin Screaton of Imperial College. “Rather than binding to a single protein on the surface of the virus, these antibodies target a molecular bridge between two proteins. Although the 4 strains of Dengue virus have variations in their surface proteins, the molecular bridge is the same, enabling the antibodies to neutralize all the different types.”

The study identified the existence of a region in the Dengue virus envelope protein (VEP) that is exposed to antibodies to all 4 serotypes, suggesting that antibodies specific for this region may be effective in neutralizing the virus and so provide a promising target for an effective vaccine.

The team from Imperial College had already succeeded in identifying and isolating antibodies that simultaneously neutralize all 4 virus serotypes in a cohort of patients infected in Thailand. Such antibodies could themselves be used to protect against or treat infections; or vaccines could be devised. However, the mode of action of these antibodies remained unknown. In the new study, using the SOLEIL and ESRF synchrotron radiation facilities in Saint-Aubin (near Paris and Grenoble respectively), the scientists carried out a crystallographic analysis of the VEP in complex with these isolated antibodies in order to determine the 3D structure. Their analyses succeeded in identifying the antibody binding site on the VEP, and determined that the amino acid sequence at this site is identical in all 4 serotypes.

They also discovered that the VEP antibody binding site doubles as the binding site for the viral protein prM. Interaction between VEP and prM is crucial for the production of infectious viral particles during virus replication in infected cells. These observations provided insight into why this common binding site has been highly conserved despite the flaw it may appear to represent: a slight mutation on this site would enable the virus to evade the immune system but, at the same time, prevent the interaction with prM essential for replication.

This site may turn out to be the “Achilles heel” of the dengue virus. It opens new possibilities for developing a unique antigenic determinant to mimic this site that may trigger an immune response targeting all 4 serotypes simultaneously and so constitute a prime vaccine candidate against dengue.

The study, by Rouvinski A, et al, was published online January 12, 2015, in the journal Nature. The earlier study (on isolating the patient antibodies that recognize all 4 serotypes), by Dejnirattisai W, et al, was published online December 15, 2014, in the journal Nature Immunology.

Related Links:

Institut Pasteur
Imperial College London
Centre national de la recherche scientifique (CNRS)


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Strips
11 Parameter Urine Strips
New
Lab Sample Rotator
H5600 Revolver

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.